Vytorin News
Congress widens probe of Vytorin makers - Forbes
The controversial study found Vytorin wasn't as effective as advertised. The fallout has hammered the stocks of both companies, cut sales of Vytorin, ...
Click here for an archive of Cramer's "Mad Money" recaps. - TheStreet.com
all 4 news articles
UPDATE 1-New York to file intent to sue health firm-source - Reuters
The drugmakers, who sell Vytorin and a related medicine, Zetia, through a joint venture, have been under scrutiny since a study showed the drug did not ...
Aegerion Pharmaceuticals: Capitalize on Cholesterol - Seeking Alpha
As of writing this analysis, Merck (MRK) announced the results of its ENHANCE trial pitting their statin/ezetimibe combination drug Vytorin against statin ...
Schering-Plough Posts a Loss on Acquisition Costs (Update1) - Bloomberg
12 (Bloomberg) -- Schering-Plough Corp., the maker of Vytorin and Zetia for cholesterol, reported a fourth-quarter loss on charges from its purchase of ...
UPDATE: Schering-Plough Swings To 4Q Loss On Organon Charges - CNNMoney.com
Prescriptions for Vytorin, a combination of simvastatin and Zetia, took a hit in January after a study showed it performed no better than generic ...
Earnings Preview: Schering-Plough - Seeking Alpha
A recent Barron's article said cholesterol drug Vytorin's woes that have plagued Merck and Schering-Plough will have a more pronounced effect on Schering. ...
Vytorin puts a CEO in a pinch - Therapeutics Daily (subscription) (press release)
The furor over Vytorin threatens the reputation of the drug industry's golden boy and, some say, his job. Schering-Plough and Merck & Co., ...
Merck and Schering-Plough Relieved Public Is Forgetting Vytorin ... - OpEdNews
by Martha Rosenberg Page 1 of 2 page(s) Prescriptions for cholesterol drug Vytorin were down 22 percent in the weeks following the release in January of the ...
Vytorin Worries Look Overdone in Shares of Merck & Schering Plough - Seeking Alpha
Last year, new warning labels essentially crippled the anemia drug franchise at Amgen (AMGN), and a recently released study for Vytorin, a cholesterol drug ...
Vytorin RSS Feed